KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $337.0 million.

  • Bausch Health Companies' Capital Expenditures rose 28.17% to $91.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $411.0 million, marking a year-over-year increase of 24.92%. This contributed to the annual value of $337.0 million for FY2024, which is 56.74% up from last year.
  • Per Bausch Health Companies' latest filing, its Capital Expenditures stood at $337.0 million for FY2024, which was up 56.74% from $215.0 million recorded in FY2023.
  • Over the past 5 years, Bausch Health Companies' Capital Expenditures peaked at $337.0 million during FY2024, and registered a low of $215.0 million during FY2023.
  • Moreover, its 3-year median value for Capital Expenditures was $218.0 million (2022), whereas its average is $256.7 million.
  • In the last 5 years, Bausch Health Companies' Capital Expenditures decreased by 18.96% in 2022 and then soared by 56.74% in 2024.
  • Bausch Health Companies' Capital Expenditures (Yearly) stood at $302.0 million in 2020, then decreased by 10.93% to $269.0 million in 2021, then decreased by 18.96% to $218.0 million in 2022, then decreased by 1.38% to $215.0 million in 2023, then surged by 56.74% to $337.0 million in 2024.